|
‘Informal’ Process May Speed Harmonized Quality Standards Between U.S., UK
The U.S. Pharmacopoeial Convention (USP) and British Pharmacopoeia (BP) have developed two drug product quality standards under a new, flexible approach that signals a drive toward speedier and more creative harmonization — and a potential break for drugmakers.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives